Evoke Pharma, Inc.

Q1 2023 13F Holders

Symbol
EVOK
CUSIP
30049G203
Type
Equity
Class
COM NEW
Num filings
13
Total reported value, excl. options
$131 k
Manager Report Date Value ($000) Shares Option Type